External Validation of a Machine Learning Model for Schizophrenia Classification

Author:

He Yupeng1ORCID,Sakuma Kenji2,Kishi Taro2,Li Yuanying3ORCID,Matsunaga Masaaki1ORCID,Tanihara Shinichi4,Iwata Nakao2,Ota Atsuhiko1ORCID

Affiliation:

1. Department of Public Health, Fujita Health University School of Medicine, Toyoake 470-1192, Japan

2. Department of Psychiatry, Fujita Health University School of Medicine, Toyoake 470-1192, Japan

3. Department of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

4. Department of Public Health, School of Medicine, Kurume University, Kurume 830-0011, Japan

Abstract

Background and Objective: Excellent generalizability is the precondition for the widespread practical implementation of machine learning models. In our previous study, we developed the schizophrenia classification model (SZ classifier) to identify potential schizophrenia patients in the Japanese population. The SZ classifier has exhibited impressive performance during internal validation. However, ensuring the robustness and generalizability of the SZ classifier requires external validation across independent sample sets. In this study, we aimed to present an external validation of the SZ classifier using outpatient data. Methods: The SZ classifier was trained by using online survey data, which incorporate demographic, health-related, and social comorbidity features. External validation was conducted using an outpatient sample set which is independent from the sample set during the model development phase. The model performance was assessed based on the sensitivity and misclassification rates for schizophrenia, bipolar disorder, and major depression patients. Results: The SZ classifier demonstrated a sensitivity of 0.75 when applied to schizophrenia patients. The misclassification rates were 59% and 55% for bipolar disorder and major depression patients, respectively. Conclusions: The SZ classifier currently encounters challenges in accurately determining the presence or absence of schizophrenia at the individual level. Prior to widespread practical implementation, enhancements are necessary to bolster the accuracy and diminish the misclassification rates. Despite the current limitations of the model, such as poor specificity for certain psychiatric disorders, there is potential for improvement if including multiple types of psychiatric disorders during model development.

Funder

Ministry of Health, Labour and Welfare

Publisher

MDPI AG

Reference36 articles.

1. National Cancer Center Institute for Cancer Control (2024, February 29). Development and Validation of a 5-Year Predictive Model for Type 2 Diabetes Risk. (In Japanese).

2. Survival estimates stratified by the Nottingham Prognostic Index for early breast cancer: A systematic review and meta-analysis of observational studies;Gray;Syst. Rev.,2018

3. External validation of clinical prediction models: Simulation-based sample size calculations were more reliable than rules-of-thumb;Snell;J. Clin. Epidemiol.,2021

4. (2024, February 29). Development of a Prevalence Estimation Method for Out-of-Hospital Schizophrenia and Schizophrenia-Related Disorders in the General Population Using Large-Scale Epidemiological Study Data and Medical Reimbursement Statement Data. Ministry of Health, Labour and Welfare Grants System. (In Japanese).

5. Global Epidemiology and Burden of Schizophrenia: Findings from the Global Burden of Disease Study 2016;Charlson;Schizophr. Bull.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3